12079499.txt 0 functional group interactions     5ht3r antagonist
12079499.txt 1 abstract  background  lerisetron   competitive serotonin type 3 receptor 5ht3r antagonist contains five functional groups capable   interacting   amino acids     5ht3r binding site site directed mutagenesis studies     5ht3ar have revealed several amino acids     thought   form part     binding domain     receptor   specific functional groups     ligand   interact   these amino acids   however unknown using synthetic analogs   lerisetron   molecular probes   combination   site directed mutagenesis   have identified some   these interactions   have proposed   model     lerisetron binding site  results  two analogs   lerisetron were synthesized   probe 5ht3r functional group interactions     compound analog 1 lacks   n1 benzyl group   lerisetron   analog 2 contains oxygen   place     distal piperazine nitrogen both analogs show significantly decreased binding affinity   wildtype 5ht3asrs mutations   w89 r91 y142   y152 produced significant decreases   binding compared   wildtype receptors binding affinities   analogs 1   2 were altered only   mutations   w89   y152  conclusions  based     data obtained   lerisetron   analogs 1   2   have proposed   tentative model     lerisetron binding pocket     5ht3asr according     model   nbenzyl group interacts     weak interaction   r91 while   benzimidazole group interacts   w89   data support an interaction     distal amino nitrogen   y142   y152
12079499.txt 2 
12079499.txt 3   cysteineloop family   ligand gated ion channels lgic   comprised   receptors   pentameric quaternary structure     least two ligand binding sites present     subunit interfaces    receptor family   characterized     presence     critical disulfide loop structure within   binding site   an integral ion selective channel lgic receptors   found   both   peripheral   central nervous systems members     family include   acetylcholine receptors    gammaamino butyric acid type   receptor gabaar      glycine receptor glyr    first subunit     5ht3r was cloned   1991    sequence     subunit was shown     highly homologous   lgic receptors   thus identified   5ht3r receptor   another member     superfamily  similar   other lgic receptors   than one subtype has been identified two splice variants   an   subunit long   short forms     single b subunit have been cloned  both   long   short forms       subunit   capable   forming functional homomeric receptors 5ht3alr   5ht3asr although some differences between an agonist   partial agonist activity have been observed    third subtype   formed     combination         b subunits   produce   heteromeric receptor   unknown stoichiometry  heteromeric receptors   pharmacologically   functionally distinct     homomeric 5ht3al   5ht3as receptors  5ht3rs   distributed throughout   central   peripheral nervous system playing   significant role   phenomenon such   anxiety emesis   alcoholism antagonists   5ht3rs   clinically efficacious     treatment   chemotherapyinduced emesis    recent studies   human subjects have suggested their potential application     treatment   early onset alcoholism  hibert et al proposed an early model     antagonist pharmacophore     5ht3r  according     model   5ht3r antagonists contain an aromatic ring   carbonyl oxygen   bioisosteric equivalent     basic nitrogen according   hiberts model   basic nitrogen   located 52a     centre     aromatic ring   approximately 17a above plane     ring   carbonyl oxygen     aromatic ring   coplanar   separated     distance   33a recent studies have expanded     model   include another lipophilic region     second hydrogen bonding interaction two atoms away     first    compound   contains   five pharmacophoric regions was synthesized   orjales et al   compound 1phenylmethyl2piperizinyl benzimidazole   lerisetron   shown   figure        potent 5ht3r antagonist functional groups     compound capable   forming interactions     receptor     distal amino group   benzimidazole     benzyl group     n1 position     benzimidazole while lerisetron contains   carbonyl group   second nitrogen contained     benzimidazole heterocycle could act   bioisostere     functional group  orjales demonstrated   importance     nbenzyl group   synthesizing several n1 substituted analogs   lerisetron removal     nbenzyl group produced   80fold decrease   affinity indicating   role     group   interacting     5ht3r other studies have supported   observation   suggest     specific electrostatic interaction  figure 1   5ht3r antagonists  5ht3r antagonists granisetron   lerisetron   shown along     two analogs utilized   probe   functional group interactions   binding site amino acids analog 1 lacks   nbenzyl functional group analog 2 contains oxygen   place     distal piperazine nitrogen while structureactivity relationship studies   molecular modeling have led     development     detailed pharmacophore model determining specific point interactions between 5ht3 antagonists   binding site amino acids has proven difficult mutagenesis studies have identified   interaction   amino acids w89   r91     binding   5ht3r ligands  studies conducted     laboratory have identified three additional putative binding site residues y140 y142   y152  w89   r91   present     conserved region   lgic receptors often referred     loop    similarly y140 y142   y152   located     region homologus   e loop region   nicotinic achr     study   have endeavoured   identify   amino acids interacting     different functional groups present     lerisetron molecule   order   develop   model   interaction     compound     5ht3r using site directed mutagenesis   combination   analogs   lerisetron   have identified amino acids   appear   interact selectively     terminal amino group   nbenzyl group     aromatic benzimidazole
12079499.txt 4 functional activity   lerisetron  whole cell patchclamp experiments were performed   test   functional activity   lerisetron   response was observed when lerisetron was applied alone data   shown when coapplied   5ht lerisetron inhibited   absolute magnitude     response     apparent alteration     response profile    combination   several identical inhibition experiments produced   ki value   02  003 nm   lerisetron inhibition     5ht induced response these data correspond well   previously reported data     compound    verify   competitive antagonist action   lerisetron analogs   lerisetron have been shown   inhibit 5ht3rs     similar manner  figure 2   inhibition   5ht induced responses   lerisetron  inhibition   5ht induced responses   lerisetron tsa 201 cells transfected   5ht3asr cdna were clamped     holding potential   60 mv   perfused   4 mum 5ht lower trace   4 mum 5ht   03 nm lerisetron upper trace lerisetron reduced   peak 5ht induced currents   20 na   10 na     change     response characteristics an ic50 value was determined     combination   similar experiments   determined     04  003 nm  importance     nbenzyl   distal piperazine nitrogen   binding   lerisetron    ki value   lerisetron inhibition   3hgranisetron binding   wildtype receptors was determined     08  019 nm figure    table    value agrees   previously published data     compound   ki values   analogs 1   2 under identical conditions   25  32 nm   320  82 nm respectively figure  table    observed change   ki represents   decreases   binding energy resulting   removal     nbenzyl group analog 1     distal piperazine nitrogen analog 2 figure 3   inhibition   3hgranisetron binding   mutant   wildtype receptors   lerisetron  inhibition   3hgranisetron binding   mutant   wildtype receptors   lerisetron competition binding assays were performed   described   materials   methods each point represents   mean  se   n4 experiments ki values calculated     data     relative magnitude     shift   ki compared   wildtype receptors   shown   table  y140a produced   significant change   ki values w89f w89y   r91a mutations produced moderate increases   ki y142a   y152a mutations resulted   increases   ki   160   190 fold respectively figure 4   inhibition   3hgranisetron binding   wildtype   mutant receptors   analog 1   analog 2  inhibition   3hgranisetron binding   wildtype   mutant receptors   analog 1   analog 2 competition binding assays were performed   described   materials   methods each point represents   mean  se   n 4 experiments ic50 values were determined     data     ki value calculated using   chengprusoff equation ki values   inhibition   each mutant   shown   table      three compounds   wildtype b w89f c w89y   r91a e y142a f y152a table 1  summary   inhibition data obtained   lerisetron analog 1   analog 2   mutant   wildtype receptors ki values were calculated   ic50 values   previously described   data     result   n  4 experiments     expressed     mean  se   relative change   ki was calculated     ki mutant  ki wildtype   indicates   increase   ki relative   wildtype  se  indicates significant difference   fold change value kd values   3hgranisetron binding   wt   mutant receptors were reproduced   reference 25  identification   amino acids interacting   lerisetron    order   determine   nature     amino acids interacting     distal amino   nbenzyl groups   lerisetron   constructed 5ht3asrs containing mutations   w89 r91 y140 y142   y152 figure  shows inhibition   3hgranisetron binding   lerisetron   wildtype   mutant receptors   most amino acids an alanine substitution was constructed   order   effectively remove any amino acid interaction     ligand   w89 an alanine substitution has been shown   prevent binding   3hgranisetron therefore   less severe mutation was constructed   w89f mutation produces   18fold change   kd   3hgranisetron binding 18  2 nm     w89y mutation produces   58fold change   kd 57  07 nm mutation   amino acid r91   alanine produced   5fold change   kd   3hgranisetron binding 49  07 nm  these data agree well   previously reported values  alanine mutations     tyrosine positions y140 y142   y152 also produced minor increases   kd   3hgranisetron binding 27  019 nm 45  05 nm   78  11 nm respectively   only small changes   ki   lerisetron were observed     y140a mutation while   y142a   y152a mutations produced large increases     ki table    figure    w89f   w89y   changes   ki observed   lerisetron were much smaller than     alanine mutations   y142a   y152a   would   expected     less severe nature   these mutations   changes were however significant p  0001   both cases     similar     changes   kd reported   3hgranisetron   increase   ki     w89f mutant receptor was 48  056 fold     increase   ki     w89y receptor was 36  04 fold   r91a mutant produced an increase   ki   76  15 fold   compared     wildtype receptor these data indicated potential interactions   lerisetron   w89 r91 y142   y152  mutation   w89    mentioned above   lack   3hgranisetron binding   w89a mutant receptors necessitated   use   w89f   w89y mutations   analyze functional group interactions   effects   these mutations     ki   analogs 1   2   shown   figure     table  analog 1 inhibited 3hgranisetron binding   w89f receptors     ki   170  54 nm 7  32 fold increase p  0001   w89y receptors     ki   81  14 nm 32  06 fold increase p  0001   reflects   significant increase   ki   reflects   potential interaction   analog 1   w89   strength     interaction   apparently similar     strength     interaction   3hgranisetron   lerisetron since   magnitude     change   similar   both cases analog 2 also showed   significant increase   ki     result     w89f   w89y mutations   magnitude     change   w89f 51  13 fold p  005 was similar     observed   lerisetron   analog 1   w89y mutation produced   68  16 fold change   ki p  005 thus   three compounds appear   form similar interactions   w89  mutation   r91  mutation   r91   alanine r91a resulted     significant   small increase   ki   lerisetron   76  15 fold p  001 figure  shows   inhibition   3hgranisetron binding   analogs 1   2   r91a mutant receptors   significant change   ki was observed   these receptors   either analog 1 09  028 fold   analog 2 056  014 fold    compared     wildtype receptor  mutation   y142  mutation   y142   alanine produced one     largest observed changes   ki   lerisetron figure    table    ki obtained   lerisetron was 130  28 nm reflecting   change   160  37 fold compared   wildtype receptors   ki value   analog 1   contrast increased only 68  23 fold p  001     result     mutation figure    table    ki   analog 2 showed   similar change   17  077 fold p  001 while these ki values   significantly different   wildtype values   each analog   lack   larger effects suggests   neither analog 1 nor analog 2 bind   strongly   lerisetron   y142  mutation   y152    y152a mutation showed   most variability   its effects   ki values   lerisetron analog 1   analog 2 figure  figure    table  lerisetron inhibited 3hgranisetron binding     ki value   150  36 an increase   190  43 fold compared   wildtype values   ki value   analog 1 increased   25  32 nm wildtype   25  040 mum   change   100  16 fold   slightly smaller     significantly different     relative change observed   lerisetron   ki   analog 2 increased   032  008 mum   wildtype   13  42 mum   y152a mutant receptors 40  12 fold increase   increase observed   analog 2 was significantly less than   observed   both lerisetron   analog 1   smaller change   ki   analog 2 suggests   analog 2 binds weakly   y152 while lerisetron   analog 1 bind   tightly
12079499.txt 5   purpose     study was   ascertain   functional group interactions   lerisetron   specific amino acids present     5ht3r binding site     end   examined   effects   specific amino acid mutations     binding   lerisetron   two analogs these analogs shown   figure    identical   lerisetron   structure however each analog lacks   single functional group found   lerisetron   comparing   effects     specific amino acid mutation     ki   inhibition   3hgranisetron binding   can begin   identify   functional groups likely   participate     interaction five different amino acids were tested w89 r91 y140 y142   y152 each   these amino acids has been shown   previous studies   alter   binding   5ht3r ligands    summary     changes   ki   presented     bar chart   figure     figure 5   relative increases   ki   lerisetron analog 1   analog 2   mutant   wildtype receptors  relative increases   ki   lerisetron analog 1   analog 2   mutant   wildtype receptors   relative change   ki was determined   ki mutant ki wildtype   each compound   w89y w89f r91a b y140a y142a y152a lerisetron showed   significant increase   ki     mutants except y140a increases   ki were observed   analog 1   2   w89   y152a while lerisetron binds   wildtype receptors   high affinity analog 1 binds   lower affinity 31 fold increase   ki compared   lerisetron analog 2   lacks   terminal nitrogen   lerisetron binds   even lower affinity   400fold fold increase   ki compared   lerisetron   table  these data demonstrate   relative importance     nbenzyl     terminal nitrogen moieties   lerisetron binding cationpi interactions involving aromatic residues     quaternary ammonium have been demonstrated   play   major role   binding   nicotinic ligands   nachrs    data support   similar role   y142   y152   binding   lerisetron     5ht3a receptor functional group interactions   w89    w89f mutation produced   significant increase   ki     three compounds   magnitude     change was similar     cases   addition   increase   ki was identical     increase   kd   has been observed   3hgranisetron binding     mutant  alterations   ki resulting     w89y mutation were slightly less however   change was again   same   lerisetron analog 1   analog 2 these data suggest     three compounds form binding site interactions   w89   interaction between lerisetron   w89   unlikely     via   nbenzyl functional group since   ki   analog 1 was also altered     mutation   same argument can   made     distal piperazine nitrogen since   ki   analog 2 also increased   portion     molecule common     three compounds   aromatic benzimidazole   thus   most likely point   interaction   w89  functional group interactions   r91    r91a mutation increased   ki value   lerisetron inhibition   3hgranisetron binding   76 fold       moderately small change   an alanine mutation particularly considering     smallest change   ki   removal     functional group   lerisetron   nbenzyl group was 31 fold     therefore likely     interaction   either extremely weak     change   ki     result     structural change     binding site previous studies concluded   r91 was an important interaction     5ht3r agonist 5hydroxytryptamine 5ht since   ki   5ht inhibition increased over 3000 fold     result     r91a mutation    change   kd   3hgranisetron binding   r91a was also observed   order   determine whether   nbenzyl   distal piperazine nitrogen   lerisetron was involved   an interaction   r91   tested both analog 1   2   r91a mutant receptors   change   ki was observed   either compound   result makes   much   difficult   assign   correct functional group     amino acid since   suggests   one   both     compounds     longer binding   receptor   precisely   same manner   lerisetron considering   small change observed   lerisetron binding     result     mutation even   slight reorientation     molecule     binding site could result     loss     interaction  functional group interactions   y142    ki values   inhibition   3hgranisetron binding   analogs 1   2 were altered only slightly     y142a mutation   magnitude     increase   ki   lerisetron however was considerably larger 160 fold     indicative   an important interaction     compound   y142   lack     large change   ki   both analogs makes   difficult   interpret   data since one   both     compounds appears     interacting differently     binding site than lerisetron analogs 1   2 differ   each other both     functional groups contained     molecule   their structural similarity   lerisetron analog 2   most similar   overall structure   substitution   oxygen     distal amino nitrogen alters   potential interactions formed     position     likely   have   small effect     overall size   shape     molecule analog 1   far less similar   lerisetron     similar     5ht3r antagonist granisetron previous studies have shown     binding   granisetron     affected     y142a mutation  analog 1 may bind   similar   granisetron than lerisetron   thus would   unaffected   mutations   y142     less likely       case   analog 2   strength     putative interaction   y142 can   identified   examining   change   binding   lerisetron     result     y142a mutation   y142a mutation produced   160 fold change   ki   change reflects   binding energy lost     result     alanine substitution   observed change   ki   wt receptors   much larger than   observed   removal     nbenzyl group 31 fold     similar     observed   substitution     distal amino nitrogen   analog 2 400 fold taken together     close structural similarity   analog 2   lerisetron   can   concluded   comparison   analog 2   lerisetron should provide   best means   identifying   interaction   y142   change   ki was observed   analog 2     result     y142a mutation indicating   lack   any significant interaction     compound   y142 these data support   hypothesis   y142 interacts     distal piperazine nitrogen   lerisetron   second amino acid may also   involved since   change   ki   lerisetron binding     result     y142a mutation was smaller than   change produced   substitution     piperazine nitrogen   described below one candidate     second amino acid   y152  functional group interactions   y152    y152a mutation produced increases   ki     three compounds although   magnitude     change differed   increases     ki values were 190 fold   lerisetron 98 fold   analog 1   only 40 fold   analog 2 thus analog 1 retains much   its ability   interact   y152 despite   absence     nbenzyl group while analog 2 interacts   weakly     amino acid since   ki   analog 1   increased     y152a mutation     unlikely     nbenzyl group interacts   y152   small change   ki   analog 2 supports   partial interaction   y152     distal piperazine nitrogen although some interaction   another group   also apparent   other group would   expected       close proximity     distal nitrogen   most likely candidate     other nitrogen     piperazine ring thus y152a may form   partial interaction   both piperazine nitrogens
12079499.txt 6 figure  shows   hypothetical model     lerisetronbinding site supported     observations   model illustrates   secondary structure     region     receptor   y140   y152     loop configuration   structure   supported   sitedirected mutagenesis data    well   structural predictions obtained   other lgic receptors    recent determination     structure     nicotinic acetylcholine binding protein    shares significant homology     lgic family also supports   loop structure     part     protein   region   w89 through y93   shown     betasheet   has been hypothesized based   sitedirected mutagenesis studies     strand     5ht3r    data indicate   functional groups   lerisetron   may interact   w89 r91 y142   y152 figure 6   model     5ht3r binding site  model     5ht3r binding site   model illustrates   major points discussed     text lerisetron   shown spanning   region between       e loops     receptor both loops   illustrated   betasheets   described   side chains   presumed   point     out     page depending   their position w89 r91 y140 y142   y152   presumably extend into   binding site   terminal piperazine nitrogen   shown interacting primarily   y142     also capable   forming an interaction   y152 y152 may also form an interaction     second piperazine nitrogen w89   illustrated   forming an aromatic interaction     benzimidazole while r91   shown   close contact     nbenzyl group   data support only   weak interaction     point w89   shown interacting     aromatic benzimidazole group   lerisetron although   precise position   w89 relative     group     known   w89 interaction     group   supported     observed increase   ki   lerisetron analog 1   analog 2 since   benzimidazole group   common     three compounds       most likely point   interaction w89 also represents   common interaction     binding site   both lerisetron   3hgranisetron y142   shown interacting     distal piperazine nitrogen possibly through   cationpi interaction   orientation   an amino group interacting   an aromatic amino acid     cationpi interaction has been shown     nicotinic acetylcholine receptor   has been hypothesized   many lgic receptors    conclusion   based   both   magnitude     change observed     wild type receptor   removal     amino group 400 fold compared     effect     y142a mutation   lerisetron binding 160 fold     lack   any major change   ki   analog 2     result     mutation   data does   support an interaction     amino acid   either   nbenzyl   benzimidazole portions   lerisetron y152   shown positioned between   two piperazine nitrogens   conclusion   supported     smaller increase   ki   analog 2 40 fold compared     observed   lerisetron 190 fold these results suggest   partial interaction   y152     distal piperazine nitrogen since some change was observed   second interaction   also likely   functional group   closest proximity     distal piperazine nitrogen     other nitrogen     piperazine ring another possibility would     nbenzyl interaction however since   y152a mutation also produced   large increase   ki   analog 2   conclusion     supported     data r91   shown   interacting     nbenzyl group       difficult conclusion   make considering   small effect     r91a mutation   lerisetron binding   interaction   included     model based   structural information obtained     crystal structure   achbp    region     protein homologous   loop e   loop       5ht3a receptor suggests   loop structure   y140   y152     3residue turn containing   glycine   position 147     betastrand   w89 through y93 oriented   shown   figure    orientation   lerisetron between w89   y142a   shown would enable   nbenzyl group     positioned   close proximity   r91         case     small alteration   position   analog 1   2     binding site could result     loss     presumably weak interaction   apparent alterations     binding site location   analog 1 would   consistent     hypothesis an alternate hypothesis would place   nbenzyl group     different position interacting   another amino acid either solely     concert   r91   data support   binding site   lerisetron     5ht3r   spans       e loop regions table  shows   sequence alignment     5ht3r   alpha7 receptor     achbp   these loops sequence alignment   mouse 5ht3 ar alpha7 nachr   achbp result   alignment     proposed     e loop     5ht3 ar   corresponding regions     alpha7 nachr   achbp   amino acids w89 r91 y140 y142   y152     5ht3   r can   aligned   w53 q55 l102 r104   m114     achbp  these amino acids form   cluster     proposed acetylcholine binding domain   achbp similar     proposed     model both loops have been identified     complementary face     binding site     nachr     unknown   lerisetron utilizes amino acids     principal face although none have been identified   model   lerisetron binding     further refined   its interactions   other binding site amino acids   investigated    particular interest would   potential interactions     nbenzyl group   would account     decrease   binding affinity   analog 2 additional information gained   comparison     model     recent crystal structure     achbp demonstrates   lerisetron can   roughly fit into   binding site such       residues line up   shown     model while       direct evidence     model   correct subsequent molecular modeling     data presented     paper may provide further support     hypothesis   current model provides an initial working hypothesis   can form   basis   further investigation also while     unclear whether   information obtained     study can   extended   other 5ht3r ligands   similar approach would   useful   identifying functional group interactions   mcpbg 5ht dtc   granisetron table 2  sequence alignment     mouse 5ht3r     mouse nicotinic alpha7 receptor     achbp two sequences   shown   top sequence     putative   loop containing w89   r91 homologous   w53   q55     achbp   lower sequence shows   putative e loop   contains y140 y142   y152 homologous   l102 r104   m114     achbp
12079499.txt 7 mutagenesis  wild type 5ht3as mouse receptor cdna was derived   n1e115 neuroblastoma cells   previously described  mutant receptors were constructed using polymerase chain reaction quick change mutagenesis kit promega   mutations were confirmed   dna sequencing  cell culture methods   transfections  tsa201 cells   derivative     hek293 cell line were grown   dulbeccos modified eagles medium  mem containing 10 fbs   100unitsml penicillinstreptomycin cultures were maintained   humidified atmosphere   5 co2   37c   binding studies tsa201 cells were plated     density   5 x 106 cells75 cm2   grown   9 hours prior   transfection cells were transfected   10 mug murine 5ht3asr cdna using calcium phosphate coprecipitation new life technologies ny   incubated 36 hours prior   harvesting   whole cell patch clamp experiments tsa201 cells were plated     density   025 x 106 cells27 cm2 dish   grown 12 hours prior   transfection cells were washed   fresh culture medium   transfected   10 mug 5ht3asr cdna using qiagen superfect transfection reagent qiagen ca transfected cells were incubated     mixture   25 hours   divided into 35 mm culture dishes     density   approximately 5 x 104 cellsdish   incubated   24 hours   37c before recording  radioligand binding assay  transfected cells were scraped     dishes washed twice   dulbeccos pbs new life technologies ny   resuspended   10 ml pbs100 mm dish cells were either used fresh   frozen     step until needed immediately prior   use cells were homogenized   pbs using   glass tissue homogenizer   centrifuged   35 000 x g   30 minutes     beckman ja20 rotor membranes were washed once     pbs   resuspended   1 ml pbs100 mm dish protein content was determined using   lowry assay sigma diagnostics st louis mo binding assays were performed   pbs   kd determinations 100 mul   homogenate was incubated   37c   1 hour   varying concentrations   3h granisetron nen ma specific binding   3h granisetron was determined     bound 3h granisetron   displaced     saturating concentration     competing ligand 100 mum mcpbg   10 mum mdl72222 kd values were determined   fitting   binding data     following equation using graphpad prism san diego ca b  bmax l n  l n  kn where theta   bound ligand bmax     maximum binding   equilibrium l     free ligand concentration   n     hill coefficient   ki determinations 100 mul   homogenate was incubated   37c   2 hours   varying concentrations   inhibitor   3h granisetron nen ma binding was terminated   rapid filtration onto   gfb filters   ic50 values were calculated   fitting   data     following equation using graphpad prism san diego ca theta  1 1lic50 where theta     fractional amount   3h granisetron bound     presence   inhibitor   concentration l   compared     amount   3h granisetron bound     absence   inhibitor ic50     concentration     theta  05   ki   calculated     ic50 value using   chengprusoff equation  electrophysiological methods  transfected tsa201 cells were transferred     recording chamber   submerged   extracellular recording buffer containing 25 mm hepes ph 74 140 mm nacl 17 mm mgcl2 5 mm kcl 18 mm cacl2 patch electrodes 2 25 momega were filled   intracellular recording buffer containing 25 mm hepes ph 74 145 mm kcl 2 mm mgcl2   1 mm egta cells were clamped   whole cell configuration     holding potential   60 mv currents elicited   agonist application were measured using an axopatch 200b amplifier foster city ca under computer control datapac 2000 run technologies agonists   antagonists were dissolved   extracellular solution   delivered   cells using   rapid perfusion system warner instruments hamden ct   ec50 determinations responses were normalized     maximum response obtained     full agonist 5ht   fitted     equation psi 11ec50 c n where psi     normalized current   5ht concentration c ec50     concentration   5ht needed   obtain half maximal activation   n     apparent hill coefficient   inhibition experiments cells were exposed   inhibitor alone   30 s prior   coexposure   5ht inhibited responses were calculated     fraction     response   5ht alone data were plotted     fractional response versus   concentration   inhibitor   analysed using graphpad software   ic50 value was calculated     concentration   antagonist inhibiting   5ht evoked response   50   ki value was calculated     ic50 using   chengprusoff equation  synthesis   lerisetron   its analogs    target molecules were prepared according     general 2step synthesis reported previously   orjales et al   only slight modification  commercially available 2chlorobenzimidazole   dry dmf was treated     slight excess   nah 11eq after stirring   1 hour   room temperature one equivalent     appropriate alkyl bromide was added slowly     reaction mixture heated under reflux    5 hours   reaction was monitored   tlc reaction product was partitioned between water   methylene chloride organic layer was dried na2so4   concentrated   vacuum   solid residue was purified   flash chromatography   afforded   corresponding nsubstituted 2chlorobenzimidazole intermediates     yield   final step involved   nucleophilic substitution     2chloro group   piperazine   high temperatures   reaction was performed neat using 4 10 fold excess piperazine   typically heated     short period only 30 45 min similar workup afforded   residue   was purified   either crystallization   chromatography   yields ranged   40 95   compounds were characterized   nmr ms hrms     elemental analysis   were identical   literature reports  materials   mem penicillinstreptomycin fetal bovine serum   trypsin were obtained   new life technologies 5ht   mdl72222 were obtained   rbi 3hgranisetron 84 cimmol was purchased   new england nuclear
12079499.txt 8 
